CUSIP 47103J105COMJANXQ4 2025
51 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 11.19M | $154.42M |
| 2 | Janus Henderson Group PLC | 5.35M | $73.85M |
| 3 | Blackrock, Inc. | 4.08M | $56.31M |
| 4 | State Street Corp | 3.85M | $53.18M |
| 5 | Fmr LLC | 3.51M | $48.47M |
| 6 | Vanguard Group Inc | 2.91M | $40.11M |
| 7 | Prosight Management, LP | 2.39M | $33.02M |
| 8 | Orbimed Advisors LLC | 1.95M | $26.97M |
| 9 | Tcg Crossover Management, LLC |
| 4 | Jan 8, 2026 | Fmr LLC | 13G/A | 5.8% | 3.51M | SEC |
| 5 | Nov 7, 2025 | Janus Henderson Group PLC | 13G/A | 10.0% | 6.03M | SEC |
| 6 | Aug 14, 2025 | Janus Henderson Group PLC | 13G/A | 7.5% | 4.46M | SEC |
| 7 | Aug 14, 2025 | Paradigm Biocapital Advisors LP | 13G/A | 4.9% | 9.23B | SEC |
| 8 | Aug 12, 2025 | Adage Capital Management, L.P. | 13G/A | 4.3% | 2.52M | SEC |
| 9 | Jul 17, 2025 | Blackrock, Inc. | 13G | 5.7% | 3.35M | SEC |
| 10 | May 14, 2025 | Janus Henderson Group PLC | 13G/A | 7.8% | 4.60M | SEC |
See the full Schedule 13D/13G history for Janux Therapeutics Inc.
Unlock full history| 1.79M |
| $24.70M |
| 10 | Wellington Management Group LLP | 1.61M | $22.22M |